#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>9-17 µg/mL
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>
See Compliance Statement D: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
Serum and urine lysozyme levels may be elevated in acute myelomonocytic leukemia (FAB-M4), chronic myelomonocytic leukemia (CMML), and chronic myelocytic leukemia (CML). Increased serum lysozyme activity is present in tuberculosis, sarcoidosis, megaloblastic anemias, acute bacterial infections, ulcerative colitis, regional enteritis, and Crohn disease. Elevated levels of urine and serum lysozyme occur during severe renal insufficiency, renal transplant rejection, urinary tract infections, pyelonephritis, glomerulonephritis, and nephrosis.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
85549
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Muramidase (Lysozyme, Serum or Body Fluid) |
*ExistCrossReferences>
|